I’ve studied thousands of near-death experiences and have become convinced there’s an afterlife

…Through his decades of research, Dr Long has concluded that about 45 percent of near-death experiences include a sense of being out-of-body, in which people’s consciousness is separated from their physical being.

About three-quarters of those who experience this reported wanting to stay in the afterlife because of the immense love and joy that overtook them. More than half report seeing a ‘heavenly’ realm and around a quarter of them are enveloped in light or mist.

This also means, he added, that nearly 100 percent of those who have a brush with death no longer fear it.

His research has permanently altered the way that Dr Long cares for his patients. Previously, he would not mention his research into this particular field, but if his patients want to talk about it, he does not hold back.

Dr Long said: ‘I tell them that based on my research, I’m very confident that there’s a wonderful afterlife for all of us and that we will be reunited with our deceased loved ones. And that’s profoundly reassuring to them. To me it’s a blessing to be able to share that with them.’

source

Research and Studies on CBD and Anxiety

CBD has gained a lot of attention in recent years for its potential therapeutic benefits for anxiety. While there is some evidence to support the use of CBD for anxiety, there are also limitations to the current research, and more studies are needed to fully understand the potential benefits and risks.

What does existing research say about the potential benefits of CBD for anxiety?

Several studies investigating the potential benefits of CBD for anxiety have borne promising results. Some of the proposed benefits of CBD for anxiety, according to emerging research, include:

  • Reducing symptoms of generalized anxiety disorder (GAD) and social anxiety disorder (SAD)
  • Improving sleep in people with anxiety
  • Reducing anxiety in people with post-traumatic stress disorder (PTSD)
  • Reducing symptoms of panic disorder

In the scientific literature, any drug or substance that causes a decrease in anxiety is known as an anxiolytic. Hence CBD is the subject of ongoing research into these proposed anxiolytic properties of CBD and their underlying mechanisms. Despite the need for some caution, these initial findings are exciting for researchers and sufferers of these varying facets of anxiety alike.

source

The linked essay is a thorough review of the use of CBD to relieve anxieties. Sent by a reader and well worth viewing if topic is of interest. ABN

Do organs have a mind of their own?

Story at a Glance:
•Organ transplant recipients often experience inexplicable personality changes and memories that appear to come from donor of the organ.

•In many of those cases, it appears that emotions which were trapped in the donor (e.g., because of the donor’s sudden traumatic death) transfer into the recipient.

•This transference provides critical insights into both the nature of consciousness and ways to mitigate many of the struggles transplant recipients face.

source

This is the logic many of us used. Plus the FDA and CDC effectively banned IVM, a good reason to believe it works. The court case against the FDA is extremely simple. Almost no doctors prescribed IVM during covid for covid and almost no pharmacists filled IVM prescriptions even when legally prescribed by a doctor. Case closed, the FDA is obviously guilty of preventing use of IVM by coercing doctors and pharmacies. ABN

Pierre Kory on ivermectin

COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State

Conclusions

The natural experiment that was put into motion with the authorization of IVM use for COVID-19 in Peru in May 2020, as analyzed using data on excess deaths by locality and by state from Peruvian national health sources, resulted in strong evidence for the drug’s effectiveness. Several potential confounding factors, including effects of a social isolation mandate imposed in May 2020, variations in the genetic makeup of the SARS-CoV-2 virus, and differences in seropositivity rates and population densities across the 25 states, were considered but did not appear to have significantly influenced these outcomes.

source above

Covid showed with great clarity that clinical trials are every bit as good as peer-reviewed. During a pandemic, clinical trials are many orders of magnitude better than waiting for peer reviews because time is so important. Moreover, covid showed how deeply compromised by money, greed, hubris, cowardice and stupidity even peer-reviewed medical trials can be. If enough of us absorb this information and apply it judiciously to climate change, reasons for war, and many other policies, we will form a decent brake on the excesses of elitist power and control. ABN

More young Americans are dying – and it’s not COVID. Why aren’t we searching for answers?

Life insurance actuaries are reporting that many more people are dying – still – than in the years before the pandemic. And while deaths during COVID-19 had largely occurred among the old and infirm, this new wave is hitting prime-of-life people hard.

No one knows precisely what is driving the phenomenon, but there is an inexplicable lack of urgency to find out. A concerted investigation is in order. 

Deaths among young Americans documented in employee life insurance claims should alone set off alarms. Among working people 35 to 44 years old, a stunning 34% more died than expected in the last quarter of 2022, with above-average rates in other working-age groups, too.

source

This is from USA Today, authored by Pierre Kory. ABN

EPA Authorizes Release of 2 Billion More GMO Mosquitoes as Reports of Malaria Surface in States That Already Released Them

Locally acquired malaria has been nonexistent in the U.S. for the last 20 years. But five such cases have recently been diagnosed — four in Florida and one in Texas — the only two states that have released genetically engineered mosquitoes.

  • Genetically engineered (GE) mosquitoes created by biotechnology company Oxitec have been released in the U.S. in Florida and Texas.
  • In March 2022, the U.S. Environmental Protection Agency (EPA) granted Oxitec a two-year extension of its experimental use permit, or EUP, which would allow the biotech company to release additional GE mosquitoes in Florida as well as in four counties in California for the first time.
  • While the EPA extended Oxitec’s EUP both the Florida Department of Agriculture and California Department of Pesticide Regulation (DPR) must approve Oxitec’s testing in order for it to move forward in their states.
  • Following pushback from legislators, California’s DPR announced Oxitec voluntarily withdrew its research authorization application to test its GE mosquitoes in California.
  • Locally acquired malaria has been nonexistent in the U.S. for the last 20 years, but five such cases have recently been diagnosed — four in Florida and one in Texas.

source